-
9061por Golabi, Pegah, Elsheikh, Elzafir, Karrar, Azza, Estep, James M., Younossi, Issah, Stepanova, Maria, Gerber, Lynn, Younossi, Zobair M.“…Mental and emotional health (MEH) impairment is commonly encountered in hepatitis C patients. Although the exact mechanism remains unknown, alterations in neurotransmitter and cytokine levels maybe associated with hepatitis C virus (HCV)-related MEH issues. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9062por Erlandson, Kristine M., Zhang, Long, Lake, Jordan E., Schrack, Jennifer, Althoff, Keri, Sharma, Anjali, Tien, Phyllis C., Margolick, Joseph B., Jacobson, Lisa P., Brown, Todd T.“…Slower BMI gain among younger HIV-infected adults may be partly explained by substance use and hepatitis C infection, and suggests that lower BMI does not represent improved health. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9063por Okubo, Keita, Wada, Hiroshi, Tanaka, Atsushi, Eguchi, Hidetoshi, Hamaguchi, Masahide, Tomokuni, Akira, Tomimaru, Yoshito, Asaoka, Tadafumi, Hama, Naoki, Kawamoto, Koichi, Kobayashi, Shogo, Marubashi, Shigeru, Nagano, Hiroaki, Sakaguchi, Noriko, Nishikawa, Hiroyoshi, Doki, Yuichiro, Mori, Masaki, Sakaguchi, Shimon“…METHODS: Sera from hepatitis C virus–positive ACR patients were compared to three hepatitis C virus cirrhosis control groups and healthy volunteers. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9064por Pokorska-Śpiewak, Maria, Kowalik-Mikołajewska, Barbara, Aniszewska, Małgorzata, Pluta, Magdalena, Walewska-Zielecka, Bożena, Marczyńska, Magdalena“…In CHC, steatosis occurred more frequently in patients with hepatitis C virus genotype 3 compared with other genotypes (P = 0.002). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9065por García-Álvarez, Mónica, Berenguer, Juan, Jiménez-Sousa, María A., Pineda-Tenor, Daniel, Aldámiz-Echevarria, Teresa, Tejerina, Francisco, Diez, Cristina, Vázquez-Morón, Sonia, Resino, Salvador“…The mechanisms involved in the chronic hepatitis C progression are incompletely understood. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9066por Cousien, Anthony, Leclerc, Pascale, Morissette, Carole, Bruneau, Julie, Roy, Élise, Tran, Viet Chi, Yazdanpanah, Yazdan, Cox, Joseph“…CONCLUSIONS: The current level of treatment access in Montréal is limiting a massive decrease in hepatitis C burden among PWID. A substantial treatment scale-up, regardless of fibrosis level, is necessary. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9067por Mohsen, Waled, Rodov, Marcia, Prakoso, Emilia, Charlton, Barbara, Bowen, David G, Koorey, David J, Shackel, Nicholas A, McCaughan, Geoffrey W, Strasser, Simone I“…One thousand and seventy-eight patients were categorized into three groups, based on the etiology of their liver disease: hepatitis B virus (HBV), hepatitis C virus (HCV) and non-viral liver disease (NVLD). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9068por Rytsareva, Inna, Campo, David S., Zheng, Yueli, Sims, Seth, Thankachan, Sharma V., Tetik, Cansu, Chirag, Jain, Chockalingam, Sriram P., Sue, Amanda, Aluru, Srinivas, Khudyakov, Yury“…BACKGROUND: Hepatitis C is a major public health problem in the United States and worldwide. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9069por Khatib, Ahmed, Matiko, Eva, Khalid, Farhat, Welty, Susie, Ali, Ameir, Othman, Asha, Haji, Shaaban, Dahoma, Mohammed, Rutherford, George“…BACKGROUND: People who inject drugs are at high risk of acquiring hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) due to risky injection and sexual practices. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9070por Wang, Junna, Li, Jiajun, Zhou, Quan, Zhang, Dandan, Bi, Qiu, Wu, Yulin, Huang, Wenxiang“…When stratified by etiology, a nonlinear association was also found in patients infected with hepatitis C virus and those coinfected with hepatitis C virus and human immunodeficiency virus. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9071por Choi, Won-Il, Dauti, Sonila, Kim, Hyun Jung, Park, Sun Hyo, Park, Jae Seok, Lee, Choong Won“…CONCLUSIONS: Smoking, hepatitis C, history of tuberculosis, history of pneumonia, chronic obstructive pulmonary disease, male sex, and older age were significantly associated with interstitial lung disease development.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9072por Hernández-Arriaga, Gustavo, Ruglas, Karen, Alas-Pineda, César, Chinchilla-López, Carmen, Arriaga-Mendoza, Glenda, Bejarano-Cáceres, Suyapa, Mejía, Christian R.“…RESULTS: The proportions of donors who tested positive for syphilis, core hepatitis, hepatitis B, human T-cell lymphotropic virus, human immunodeficiency virus, and hepatitis C infections were 45% (n = 447), 35% (348), 11% (105), 10% (97), 6% (59), and 3% (24), respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9073por Meda, Nicolas, Tuaillon, Edouard, Kania, Dramane, Tiendrebeogo, Adama, Pisoni, Amandine, Zida, Sylvie, Bollore, Karine, Medah, Isaïe, Laureillard, Didier, Moles, Jean Pierre, Nagot, Nicolas, Nebie, Koumpingnin Yacouba, Van de Perre, Philippe, Dujols, Pierre“…FINDINGS: We estimated seroprevalence as 9.1% (95% confidence interval, CI: 8.5–9.7) for the hepatitis B surface antigen and 3.6% (95% CI: 3.3–3.8) for hepatitis C virus antibodies, classifying Burkina Faso as highly endemic for hepatitis B and low-intermediate for hepatitis C. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9074por Rezaei, Negar, Asadi-Lari, Mohsen, Sheidaei, Ali, Khademi, Sara, Gohari, Kimiya, Delavari, Farnaz, Delavari, Alireza, Abdolhamidi, Elham, Chegini, Maryam, Rezaei, Nazila, Jamshidi, Hamidreza, Bahrami Taghanaki, Pegah, Hasan, Milad, Yoosefi, Moein, FarzadFar, Farshad“…Cirrhosis mortality could be diminished by using new non-invasive methods of cirrhosis screening, hepatitis B vaccination, definite treatment of hepatitis C.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9075“…We recommend the one from the University of Liverpool for patients under HIV-therapy (https://www.hiv-druginteractions.org/checker), while for patients under hepatitis C-therapy, we advise to consult http://www.hep-druginteractions.org/. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9076por Iddi, Shabani, Minja, Caroline A., Silago, Vitus, Benjamin, Asteria, Mpesha, Jastine, Henerico, Shimba, Kidenya, Benson R., Mshana, Stephen E., Mirambo, Mariam M.“…Hepatitis B virus (HBV) and Hepatitis C virus (HCV) detection and liver enzymes assays (alanine transaminase (ALAT) and aspartate transaminase (ASAT)) were assessed following the standard procedures. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9077por Christiansen, D., Earnest-Silveira, L., Grubor-Bauk, B., Wijesundara, D. K., Boo, I., Ramsland, P. A., Vincan, E., Drummer, H. E., Gowans, E. J., Torresi, J.“…The introduction of directly acting antiviral agents (DAAs) has produced significant improvements in the ability to cure chronic hepatitis C infection. However, with over 2% of the world’s population infected with HCV, complications arising from the development of cirrhosis of the liver, chronic hepatitis C infection remains the leading indication for liver transplantation. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9078por Calner, Paul, Sperring, Heather, Ruiz-Mercado, Glorimar, Miller, Nancy S., Andry, Chris, Battisti, Leandra, Scrudder, Katy, Shea, Fiona, Chan, Angelica, Schechter-Perkins, Elissa M.“…BACKGROUND: It is unclear whether sites that screen large numbers of patients for Hepatitis C Virus but achieve limited follow-up are more or less effective at having patients succeed through linkage and treatment than lower volume sites that have higher linkage percentages. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9079por Wang, Yijin, Rao, Huiying, Chi, Xiumei, Li, Boan, Liu, Hongyang, Wu, Liyuan, Zhang, Hao, Liu, Shuhong, Zhou, Gaungde, Li, Na, Niu, Junqi, Wei, Lai, Zhao, Jingmin“…BACKGROUND: Whether achieving sustained virological response (SVR) in patients with hepatitis C attains complete elimination of hepatitis C virus (HCV) is unknown, because occult HCV infection (OCI), defined as the detection of HCV-RNA in hepatocytes or peripheral blood mononuclear cells (PBMC) in absence of serum HCV-RNA, may occur. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9080por Unger, Lukas W., Forstner, Bernadette, Schneglberger, Stephan, Muckenhuber, Moritz, Eigenbauer, Ernst, Scheiner, Bernhard, Mandorfer, Mattias, Trauner, Michael, Reiberger, Thomas“…Accordingly, LDL-cholesterol levels were significantly lower in ACLD due to hepatitis C, hepatitis B, metabolic/fatty liver disease and autoimmune hepatitis. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto